Portal de Periódicos da CAPES

Quality-of-life measurements in the evaluation of treatment: proposed guidelines.

1995; Wiley; Volume: 39; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2125.1995.tb04439.x

1365-2125

Astrid Fletcher,

Healthcare Policy and Management

British Journal of Clinical PharmacologyVolume 39, Issue 3 p. 217-222 Free Access Quality-of-life measurements in the evaluation of treatment: proposed guidelines. A Fletcher, A Fletcher Department of Epidemiology and Population Sciences, London School of Hygiene and Tropical Medicine.Search for more papers by this author A Fletcher, A Fletcher Department of Epidemiology and Population Sciences, London School of Hygiene and Tropical Medicine.Search for more papers by this author First published: March 1995 https://doi.org/10.1111/j.1365-2125.1995.tb04439.xCitations: 27AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Wilkin D, Hallam L, Doggett M. Measures of need and outcome for primary health care. Oxford: Oxford University Press, 1992. 2 Fallowfield L. The quality of life. London: Souvenir, 1990. 3 Bowling A. Measuring health: a review of quality of life measurement scales. Milton Keynes: Open University Press, 1991. 4 McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. Oxford: Oxford University Press, 1987. 5 Hunt SM, McEwan J, McKenna SP. Measuring health status. London: Croom Helm, 1986. 6 Guyatt G, Feeny D, Patrick D. Issues in quality of life measurements in clinical trials. Controlled clin Trials 1991; 12: 81S– 90S. 7 Patrick DL, Erickson P. Assessing health related quality of life for clinical decision making. Ch 2, pp 11–63. In Quality of life assessment: key issues in the 1990s, eds SR Walker, RM. Rosser London: Kluwer Academic Publishers, 1993. 8 Wiklund I, Dimenas E, Wahl M. Factors of importance when evaluating quality of life in clinical trials. Controlled clin Trials. 1990; 11: 169– 179. 9 Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stats Med 1991; 10: 1915– 1930. 10 B Spilker (ed) Quality of life assessments in clinical trials. New York: Raven Press, 1990. 11 Maguire P, Selby P. Assessing the quality of life in cancer patients. Br J Cancer 1989; 60: 437– 440. 12 Kane RA, Kane RL. Assessing the elderly: a practical guide to measurement. Lexington: Lexington Books, 1981. 13 George LK, Bearon LB. Quality of life in older persons: meaning and measurement. New York: Human Sciences Press, 1980. 14 Erickson P, Scott J. The On-Line Guide to Quality-of-Life Assessment (OLGA): resource for selecting quality of life assessments. Ch 13, pp 221–232. In Quality of life assessment: key issues in the 1990s, eds SR Walker, RM. Rosser London: Kluwer Academic Publishers, 1993. 15 Streiner DL, Norman GR. Health Measurement Scales. A practical guide to their development and use. Oxford: Oxford Medical Publications, 1992. 16 Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch gen Psychiatry 1961; 4: 561– 571. 17 Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF36 health survey questionnaire: new outcome measure for primary care. Br med J 1992; 305: 160– 164. 18 Fava GA, Kellner R, Munari F, Pavan L. The Hamilton Depression Rating Scale in normals and depressives. Acta Psychiat Scand 1982; 66: 26– 32. 19 Robin A, Curry SH, Whelpton R. Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med 1974; 4: 388– 392. 20 Bland M, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307– 310. 21 Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Controlled clin Trials 1991; 12: 142S– 158S. 22 Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality of life assessment in cancer clinical trials. Rec Results Cancer Res 1988; 111: 231– 249. 23 McNair DM, Lorr M, Doppleman LF. Manual for the Profile of Mood states. San Diego: San Diego Educational and Industrial Testing Service, 1971. 24 Fitzpatrick R, Fletcher A, Jones D, Gore S, Spiegelhalter D, Cox D. Quality of life measures in health care. I: Applications and issues in assessment. Br med J 1992; 305: 1074– 1077. 25 Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis and interpretation. Br med J 1992; 305: 1145– 1148. 26 Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR. Quality of life assessment: can we keep it simple J Roy Stat Soc 1992; 155: 353– 393. 27 Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27: S178– S189. 28 Testa MA, Hollenberg NK, Anderson RB, Williams GH. Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertension 1991; 4: 363– 373. 29 Fletcher A, McLoone P, Bulpitt CJ. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 1988; ii: 4– 7. 30 Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH. The effects of antihypertensive therapy on the quality of life. New Engl J Med 1986; 314: 1657– 1664. 31 Fletcher AE, Bulpitt CJ, Chase D, Collins W, Furberg CD, Goggin TK, Hewett AJ, Neiss AM. Quality of life on three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499– 507. 32 Omvik P, Thaulow E, Herland OB, Eide I, Midha R, Turner RR. Double blind parallel comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study. J Hypertension 1993; 11: 103– 113. 33 Fletcher AE, Bulpitt CJ. Pharmacoeconomic evaluation of risk factors for cardiovascular disease. An epidemiological perspective. Pharmacoeconomics 1992; 1: 33– 44. 34 Spiegelhalter D, Gore SM, Fitzpatrick R, Fletcher AE, Jones DR, Cox DR. Quality of life measures in health care. III: Resource allocation. Br med J 1992; 305: 1205– 1209. Citing Literature Volume39, Issue3March 1995Pages 217-222 ReferencesRelatedInformation